Centro Jordan DE Hipnoterapia Los Angeles, CA - 90027

Centro Jordan DE Hipnoterapia is categorized under Physical Therapists in Los Angeles, CA and active since 2005.

Centro Jordan DE Hipnoterapia was established in 2005, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Physical Therapists business, which does work in the B2C market, and is classified as a Physical Therapists, under code number 6214930 by the NAICS.

If you are seeking more information, feel free to contact Juses Oliveros at the company’s single location by writing to 5107 Hollywood Boulevard, Los Angeles, California CA 90027 or by phoning (323) 667-0761. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Centro Jordan DE Hipnoterapia
Contact Person: Juses Oliveros
Address: 5107 Hollywood Boulevard, Los Angeles, California 90027
Phone Number: (323) 667-0761
Annual Revenue (USD): $1.000.000 to $2.499.999
Founded: 2005
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Physical Therapists
SIC Code: 8049
NAICS Code: 6214930
Share This Business:

Centro Jordan DE Hipnoterapia was started in 2005 to provide professional Physical Therapists under the SIC code 8049 and NAICS code 6214930. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.

Feel free to contact Juses Oliveros for inquiries that concern Centro Jordan DE Hipnoterapia by calling the company number (323) 667-0761, as your correspondence is most welcome. Additionally, the physical location of the single location of Centro Jordan DE Hipnoterapia can be found at the coordinates 34.1018,-118.30077 as well as the street address 5107 Hollywood Boulevard in Los Angeles, California 90027.

For its online presence, you may visit Centro Jordan DE Hipnoterapia’s website at and engage with its social media outlets through on Twitter and on Facebook.